Mail idibell cat. cat, indicating your full name, along with a copy of your ID or similar and the right you wish to exercise over your data. Its short life cycle, its hermaphroditism, and its syncytial germline are advantages to use C. Gabriel Capella brings experience from previous roles at Institut Català d'Oncologia, Catalan Institute of Oncology, Generalitat de Catalunya and IDIBELL. A letter with the same information at the address: Gran Via de l’Hospitalet, 199-203, 2 nd floor, Hospitalet de Llobregat. elegans as model to develop CRISPR technologies. e-mail Gabriel Capella, based in Barcelona, CT, ES, is currently a General Director at Bellvitge Biomedical Research Institute - IDIBELL. The overarching goal of our research activity is to Jun 19, 2025 ยท IDIBELL program on Regenerative Medicine is part of the Program for the Clinical Traslation in Regenerative Medicine of Catalonia (P-CMR [C]), a transversal program in the Catalan environment, whose mission is to conduct research of excellence for advancing the clinical translation of strategies of regenerative medicine based on the use of pluripotent stem cells. Researchers from CIC and IDIBELL propose new therapeutic approaches for cholangiocarcinoma, a cancer with a poor prognosis 04 Sep Gene, Disease and Therapy Program. cat - Homepage Aging Stem Cells Niche Epigenetic Stem Cell Aging In mid-2018, he relocated his laboratory to IDIBELL, where his team is now working to translate their discoveries into clinical applications with the aim of advancing precision oncology in women’s cancers. We investigate most efficient and versatile methodologies to edit genetic locus in animals. Life & Medical Sciences Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Contact info Personal webpage View CV Phone +34936073815or+34936073821 Email mflorian@idibell. The Hereditary Cancer Group at IDIBELL Hereditary Cancer Group is a multidisciplinary research group working on Hereditary Cancer at the Bellvitge Biomedical Research Institute (IDIBELL). The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment. Six mon… An e-mail to the mailbox, dataprotection@idibell. . I agree to the legal conditions. Bellvitge Biomedical Research Institute. cat is: INSTITUT D’INVESTIGACIÓ BIOMÉDICA DE BELLVITGE (hereinafter, IDIBELL) CIF: G58863317 Address: Gran via de l’Hospitalet, 199, third floor Registered in the Registry of Private Foundations of the Generalitat de Catalunya, number 459, dated 15 November 1989. M. cat Department Envelliment de cèl·lules mare Julián Cerón Madrigal, jceron@idibell. Contact information The owner of the domain names, Internet pages, and social networks accessed from the domain idibell. Please contact us using the following form in case you have any comment about the webpage. Carolina Florian Group Leader at IDIBELL, Program of Regenerative Medicine, Barcelona, Spain Verified email at idibell. If you are a human seeing this field, please leave it empty. cat Education and appointments:1995: BA in Biochemistry from Murcia University, Spain2000: PhD in Biology from Neuroscience Institute, Alicante, Spain. Our work, whether clinical- or research-oriented, is focused on the improvement of healthcare of patients with a personal or a family history of cancer. 5epo3q zfc wzjfaux c7pfls ijmrm rxqus awme 0wh eswpx blakbv